Coverart for item
The Resource Autoimmune diseases and treatment : organ-specific and systemic disorders, edited by Yehuda Shoenfeld and M. Eric Gershwin

Autoimmune diseases and treatment : organ-specific and systemic disorders, edited by Yehuda Shoenfeld and M. Eric Gershwin

Label
Autoimmune diseases and treatment : organ-specific and systemic disorders
Title
Autoimmune diseases and treatment
Title remainder
organ-specific and systemic disorders
Statement of responsibility
edited by Yehuda Shoenfeld and M. Eric Gershwin
Creator
Contributor
Subject
Genre
Language
eng
Member of
Additional physical form
Also available via the World Wide Web.
Cataloging source
DNLM/DLC
Dewey number
  • 500 s
  • 616.97/8
Illustrations
illustrations
Index
index present
LC call number
  • Q11
  • RC600
LC item number
.N5 vol. 1051
Literary form
non fiction
Nature of contents
bibliography
Series statement
Annals of the New York Academy of Sciences
Series volume
v. 1051
Label
Autoimmune diseases and treatment : organ-specific and systemic disorders, edited by Yehuda Shoenfeld and M. Eric Gershwin
Link
http://www.blackwell-synergy.com/toc/nyas/1051/1
Instantiates
Publication
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier MARC source
rdacarrier
Content category
text
Content type MARC source
rdacontent
Contents
Organ-specific autoimmune diseases. Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis. Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production. Clinical relevance of antiphospholipid antibodies in primary biliary cirrhosis. IL-10 and the cytokine network in the pathogenesis of human autoimmune hemolytic anemia. Crohn's disease is associated with polymorphism of CARD15/NOD2 gene in a Hungarian population. Apoptosis in human skin: role in pathogenesis of various diseases and relevance for therapy. Cancer-associated myositis: clinical features and prognostic signs. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis. Oxidized low-density lipoprotein/[beta]2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus. Autoantibodies to human [alpha]6 integrin in patients with bullous pemphigoid. Soluble HLA class I and class II molecules in relapsing-remitting multiple sclerosis: acute response to interferon-[beta]1a treatment and their use as markers of disease activity. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome. Rheumatic fever: How S. pyogenes-primed peripheral T cells trigger heart valve lesions. Avidity of anti-[beta]2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome. Neurological complications of celiac disease and autoimmune mechanisms: preliminary data of a prospective study in adult patients. E2F1−/−C57BL/6 mice overexpressing a human bcl-2 transgene in B cells develop a mild autimmune syndrome. Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications. Pregnancy loss and endometriosis: pathogenic role of anti-laminin-1 autoantibodies. Primary biliary cirrhosis: solving the enigma. The stages of type 1A diabetes. Soluble CD40L in plasma of patients with primary biliary cirrhosis. Decreased serum leptin levels in primary biliary cirrhosis: a link between metabolism and autoimmunity? Analysis of the foxp3/scurfin gene in Crohn's disease -- Systematic autoimmune diseases. Juvenile systemic sclerosis: a follow-up study of eight patients. Antifodrin antibodies in Sjögren's syndrome: a review. Generation and characterization of three monoclonal IgM antiphospholipid antibodies recognizing different phospholipid antigens. Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus. Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Investigation of arthritic joint destruction by a novel fibroblast-based model. Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis. Mon-organic versus multi-organic involvement in primary antiphospholipid syndrome. OxLDL/[beta]2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Anti-HSP60 immunity is already associated with atherosclerosis early in life. Determinants of vessel targeting in vasculitis. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Systemic lupus erythematosus, atherosclerosis, and autoantibodies. Accelerated atherosclerosis in patients with systemic autoimmune diseases. Nocturnal hormones and clinical rhythms in rheumatoid arthritis. Xenobiotic-induced recruitment of autoantigens to nuclear proteasomes suggests a role for altered antigen processing in scleroderma. Humoral antigenic targets of the ribosomal P0 lupus autoantigen are not limited to the carboxyl region. Clinical correlations of potential activity markers in systemic sclerosis. Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome. The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis. Cellular and molecular mechanisms of regulation of autoantibody production in lupus. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis. Predictive markers for development of severe organ involvement in patients with systemic sclerosis. Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology. New facet of antiphospholipid antibodies -- Treatment. Inhibitor development in patients with hemophilia A after continuous infusion of FVIII concentrates. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab. Synergistic effect of avemar on proinflammatory cytokine production and ras-mediated cell activation. Fermented wheat germ extract (avemar) in the treatment of cancer and autoimmune diseases. Open-label 24-month study evaluating infliximab therapy in patients with psoriatic spondyloarthropathy. Cyclosporine: from renal transplantation to autoimmune diseases. Autoimmunity and anti-TNF-[alpha] agents. Combination treatment of rat adjuvant-induced arthritis with methotrexate, probiotic bacteria Enterococcus faecium, and selenium. Comparative analysis of antigen specificities in the monomeric and dimeric fractions of intravenous immunoglobulin. Treatment of pemphigus vulgaris with protein A immunoadsorption: case report of long-term history showing favorable outcome. Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis. Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Gene-gun biolistic immunization encoding glutamic acid decarboxylase: a model for studying Langerhans cell abnormalities and mimicry in the nonobese diabetic mouse. Intra-bone marrow-bone marrow transplantation: a new strategy for treatment of stem cell disorders. Removal of pathogenic autoantibodies by immunoadsorption. Chemokine receptors: attractive targets for drug discovery. Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency. CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases. Anticytokine therapy, especially anti-interferon-[gamma], as a pathogenetic treatment in TH-1 autoimmune diseases. Therapeutic T cell-based vaccination for neurodegenerative disorders: the role of CD4+CD25+ regulatory T cells. Tumor necrosis factor inhibitor therapy for rheumatoid arthritis. Pathogenesis of rheumatoid arthritis: targeting cytokines. Anti-inflammatory and immune regulatory properties of 5-androsten-3[beta], 17[beta]-diol (HE2100), and synthetic analogue HE3204: implications for treatment of autoimmune diseases. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss. Response of vasculitic peripheral neuropathy to intravenous immunoglobulin. Involvement of innate immunity in the development of inflammatory and autoimmune diseases. Do we need new treatment that goes beyond tumor necrosis factor blockers for rheumatoid arthritis?
Dimensions
24 cm.
Extent
xiv, 815 p.
Isbn
9781573316132
Isbn Type
(pbk. : alk. paper)
Lccn
2005014243
Media category
unmediated
Media MARC source
rdamedia
Other physical details
ill.
System control number
  • UtOrBLW
  • UtOrBLW
  • (OCoLC)ocn368076173
Label
Autoimmune diseases and treatment : organ-specific and systemic disorders, edited by Yehuda Shoenfeld and M. Eric Gershwin
Link
http://www.blackwell-synergy.com/toc/nyas/1051/1
Publication
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier MARC source
rdacarrier
Content category
text
Content type MARC source
rdacontent
Contents
Organ-specific autoimmune diseases. Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis. Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production. Clinical relevance of antiphospholipid antibodies in primary biliary cirrhosis. IL-10 and the cytokine network in the pathogenesis of human autoimmune hemolytic anemia. Crohn's disease is associated with polymorphism of CARD15/NOD2 gene in a Hungarian population. Apoptosis in human skin: role in pathogenesis of various diseases and relevance for therapy. Cancer-associated myositis: clinical features and prognostic signs. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis. Oxidized low-density lipoprotein/[beta]2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus. Autoantibodies to human [alpha]6 integrin in patients with bullous pemphigoid. Soluble HLA class I and class II molecules in relapsing-remitting multiple sclerosis: acute response to interferon-[beta]1a treatment and their use as markers of disease activity. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome. Rheumatic fever: How S. pyogenes-primed peripheral T cells trigger heart valve lesions. Avidity of anti-[beta]2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome. Neurological complications of celiac disease and autoimmune mechanisms: preliminary data of a prospective study in adult patients. E2F1−/−C57BL/6 mice overexpressing a human bcl-2 transgene in B cells develop a mild autimmune syndrome. Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications. Pregnancy loss and endometriosis: pathogenic role of anti-laminin-1 autoantibodies. Primary biliary cirrhosis: solving the enigma. The stages of type 1A diabetes. Soluble CD40L in plasma of patients with primary biliary cirrhosis. Decreased serum leptin levels in primary biliary cirrhosis: a link between metabolism and autoimmunity? Analysis of the foxp3/scurfin gene in Crohn's disease -- Systematic autoimmune diseases. Juvenile systemic sclerosis: a follow-up study of eight patients. Antifodrin antibodies in Sjögren's syndrome: a review. Generation and characterization of three monoclonal IgM antiphospholipid antibodies recognizing different phospholipid antigens. Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus. Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Investigation of arthritic joint destruction by a novel fibroblast-based model. Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis. Mon-organic versus multi-organic involvement in primary antiphospholipid syndrome. OxLDL/[beta]2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Anti-HSP60 immunity is already associated with atherosclerosis early in life. Determinants of vessel targeting in vasculitis. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Systemic lupus erythematosus, atherosclerosis, and autoantibodies. Accelerated atherosclerosis in patients with systemic autoimmune diseases. Nocturnal hormones and clinical rhythms in rheumatoid arthritis. Xenobiotic-induced recruitment of autoantigens to nuclear proteasomes suggests a role for altered antigen processing in scleroderma. Humoral antigenic targets of the ribosomal P0 lupus autoantigen are not limited to the carboxyl region. Clinical correlations of potential activity markers in systemic sclerosis. Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome. The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis. Cellular and molecular mechanisms of regulation of autoantibody production in lupus. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis. Predictive markers for development of severe organ involvement in patients with systemic sclerosis. Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology. New facet of antiphospholipid antibodies -- Treatment. Inhibitor development in patients with hemophilia A after continuous infusion of FVIII concentrates. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab. Synergistic effect of avemar on proinflammatory cytokine production and ras-mediated cell activation. Fermented wheat germ extract (avemar) in the treatment of cancer and autoimmune diseases. Open-label 24-month study evaluating infliximab therapy in patients with psoriatic spondyloarthropathy. Cyclosporine: from renal transplantation to autoimmune diseases. Autoimmunity and anti-TNF-[alpha] agents. Combination treatment of rat adjuvant-induced arthritis with methotrexate, probiotic bacteria Enterococcus faecium, and selenium. Comparative analysis of antigen specificities in the monomeric and dimeric fractions of intravenous immunoglobulin. Treatment of pemphigus vulgaris with protein A immunoadsorption: case report of long-term history showing favorable outcome. Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis. Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Gene-gun biolistic immunization encoding glutamic acid decarboxylase: a model for studying Langerhans cell abnormalities and mimicry in the nonobese diabetic mouse. Intra-bone marrow-bone marrow transplantation: a new strategy for treatment of stem cell disorders. Removal of pathogenic autoantibodies by immunoadsorption. Chemokine receptors: attractive targets for drug discovery. Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency. CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases. Anticytokine therapy, especially anti-interferon-[gamma], as a pathogenetic treatment in TH-1 autoimmune diseases. Therapeutic T cell-based vaccination for neurodegenerative disorders: the role of CD4+CD25+ regulatory T cells. Tumor necrosis factor inhibitor therapy for rheumatoid arthritis. Pathogenesis of rheumatoid arthritis: targeting cytokines. Anti-inflammatory and immune regulatory properties of 5-androsten-3[beta], 17[beta]-diol (HE2100), and synthetic analogue HE3204: implications for treatment of autoimmune diseases. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss. Response of vasculitic peripheral neuropathy to intravenous immunoglobulin. Involvement of innate immunity in the development of inflammatory and autoimmune diseases. Do we need new treatment that goes beyond tumor necrosis factor blockers for rheumatoid arthritis?
Dimensions
24 cm.
Extent
xiv, 815 p.
Isbn
9781573316132
Isbn Type
(pbk. : alk. paper)
Lccn
2005014243
Media category
unmediated
Media MARC source
rdamedia
Other physical details
ill.
System control number
  • UtOrBLW
  • UtOrBLW
  • (OCoLC)ocn368076173

Library Locations

    • BYU-INTERNETBorrow it
      UT, US
    • Harold B. Lee Library Brigham Young University, Provo, UT, 84602, US
      40.249156 -111.649242
Processing Feedback ...